{"transactions":[{"id":869992,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":63544,"kind":"person","name":"DeFrancesco Lisa","position":1,"cik":"0001846325","reported_name":"DeFrancesco Lisa","relationship":{"officer":true,"officer_title":"SVP, IR and Corp Comm"}}],"security":"Restricted Stock Units","published_at":"2026-03-03T12:18:00.000Z","date":"2026-02-28","kind":"exercise","planned":false,"acquired":false,"shares":128190,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."}],"balance_after":256380,"derivative":{"underlying":"Common Stock","underlying_shares":128190},"source":{"system":"sec-edgar","filing":"0001062822-26-000037","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000037/form4.xml","form_type":"4"}},{"id":869991,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":63544,"kind":"person","name":"DeFrancesco Lisa","position":1,"cik":"0001846325","reported_name":"DeFrancesco Lisa","relationship":{"officer":true,"officer_title":"SVP, IR and Corp Comm"}}],"security":"Restricted Stock Units","published_at":"2026-03-03T12:18:00.000Z","date":"2026-02-28","kind":"exercise","planned":false,"acquired":false,"shares":24674,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."}],"balance_after":24673,"derivative":{"underlying":"Common Stock","underlying_shares":24674},"source":{"system":"sec-edgar","filing":"0001062822-26-000037","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000037/form4.xml","form_type":"4"}},{"id":869990,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":63544,"kind":"person","name":"DeFrancesco Lisa","position":1,"cik":"0001846325","reported_name":"DeFrancesco Lisa","relationship":{"officer":true,"officer_title":"SVP, IR and Corp Comm"}}],"security":"Common Stock","published_at":"2026-03-03T12:18:00.000Z","date":"2026-02-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":74572,"price":1.47,"value":109620.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto."}],"balance_after":93869,"source":{"system":"sec-edgar","filing":"0001062822-26-000037","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000037/form4.xml","form_type":"4"}},{"id":869989,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":63544,"kind":"person","name":"DeFrancesco Lisa","position":1,"cik":"0001846325","reported_name":"DeFrancesco Lisa","relationship":{"officer":true,"officer_title":"SVP, IR and Corp Comm"}}],"security":"Common Stock","published_at":"2026-03-03T12:18:00.000Z","date":"2026-02-28","kind":"exercise","planned":false,"acquired":true,"shares":128190,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":168441,"source":{"system":"sec-edgar","filing":"0001062822-26-000037","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000037/form4.xml","form_type":"4"}},{"id":869988,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":63544,"kind":"person","name":"DeFrancesco Lisa","position":1,"cik":"0001846325","reported_name":"DeFrancesco Lisa","relationship":{"officer":true,"officer_title":"SVP, IR and Corp Comm"}}],"security":"Common Stock","published_at":"2026-03-03T12:18:00.000Z","date":"2026-02-28","kind":"exercise","planned":false,"acquired":true,"shares":24674,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":40251,"source":{"system":"sec-edgar","filing":"0001062822-26-000037","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000037/form4.xml","form_type":"4"}},{"id":901908,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":63544,"kind":"person","name":"DeFrancesco Lisa","position":1,"cik":"0001846325","reported_name":"DeFrancesco Lisa","relationship":{"officer":true,"officer_title":"SVP, IR and Corp Comm"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-17T21:07:59.000Z","date":"2026-02-12","kind":"grant","planned":false,"acquired":true,"shares":386300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter."}],"balance_after":386300,"derivative":{"exercise_price":1.37,"expiration_date":"2036-02-12","underlying":"Common Stock","underlying_shares":386300},"source":{"system":"sec-edgar","filing":"0001062822-26-000022","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000022/form4.xml","form_type":"4"}},{"id":901907,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":63544,"kind":"person","name":"DeFrancesco Lisa","position":1,"cik":"0001846325","reported_name":"DeFrancesco Lisa","relationship":{"officer":true,"officer_title":"SVP, IR and Corp Comm"}}],"security":"Restricted Stock Units","published_at":"2026-02-17T21:07:59.000Z","date":"2026-02-12","kind":"grant","planned":false,"acquired":true,"shares":257530,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."}],"balance_after":257530,"derivative":{"underlying":"Common Stock","underlying_shares":257530},"source":{"system":"sec-edgar","filing":"0001062822-26-000022","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000022/form4.xml","form_type":"4"}},{"id":1236712,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":63544,"kind":"person","name":"DeFrancesco Lisa","position":1,"cik":"0001846325","reported_name":"DeFrancesco Lisa","relationship":{"officer":true,"officer_title":"SVP, IR and Corp Comm"}}],"security":"Restricted Stock Units","published_at":"2025-03-03T21:30:24.000Z","date":"2025-02-28","kind":"exercise","planned":false,"acquired":false,"shares":24673,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."}],"balance_after":49347,"derivative":{"underlying":"Common Stock","underlying_shares":24673},"source":{"system":"sec-edgar","filing":"0001127602-25-007527","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760225007527/form4.xml","form_type":"4"}},{"id":1236711,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":63544,"kind":"person","name":"DeFrancesco Lisa","position":1,"cik":"0001846325","reported_name":"DeFrancesco Lisa","relationship":{"officer":true,"officer_title":"SVP, IR and Corp Comm"}}],"security":"Common Stock","published_at":"2025-03-03T21:30:24.000Z","date":"2025-02-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":9096,"price":0.67,"value":6094.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto."}],"balance_after":15577,"source":{"system":"sec-edgar","filing":"0001127602-25-007527","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760225007527/form4.xml","form_type":"4"}},{"id":1236710,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":63544,"kind":"person","name":"DeFrancesco Lisa","position":1,"cik":"0001846325","reported_name":"DeFrancesco Lisa","relationship":{"officer":true,"officer_title":"SVP, IR and Corp Comm"}}],"security":"Common Stock","published_at":"2025-03-03T21:30:24.000Z","date":"2025-02-28","kind":"exercise","planned":false,"acquired":true,"shares":24673,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":24673,"source":{"system":"sec-edgar","filing":"0001127602-25-007527","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760225007527/form4.xml","form_type":"4"}},{"id":1264744,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":63544,"kind":"person","name":"DeFrancesco Lisa","position":1,"cik":"0001846325","reported_name":"DeFrancesco Lisa","relationship":{"officer":true,"officer_title":"VP, IR and Corp Comm"}}],"security":"Restricted Stock Units","published_at":"2025-02-18T21:20:02.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":384570,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."}],"balance_after":384570,"derivative":{"underlying":"Common Stock","underlying_shares":384570},"source":{"system":"sec-edgar","filing":"0001127602-25-005218","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760225005218/form4.xml","form_type":"4"}},{"id":1264743,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":63544,"kind":"person","name":"DeFrancesco Lisa","position":1,"cik":"0001846325","reported_name":"DeFrancesco Lisa","relationship":{"officer":true,"officer_title":"VP, IR and Corp Comm"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-18T21:20:02.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":576850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter."}],"balance_after":576850,"derivative":{"exercise_price":0.695,"expiration_date":"2035-02-13","underlying":"Common Stock","underlying_shares":576850},"source":{"system":"sec-edgar","filing":"0001127602-25-005218","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760225005218/form4.xml","form_type":"4"}},{"id":2448245,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":63544,"kind":"person","name":"DeFrancesco Lisa","position":1,"cik":"0001846325","reported_name":"DeFrancesco Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, IR & Corp. Affairs"}}],"security":"Common Stock","published_at":"2022-01-04T16:18:42.000Z","date":"2021-12-31","kind":"tax_withholding","acquired":false,"shares":542,"price":16.29,"value":8829.18,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of restricted stock unit awards previously granted to the reporting person."}],"balance_after":10308,"source":{"system":"sec-edgar","filing":"0001104659-22-000929","document":"tm221409d5_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465922000929/tm221409d5_4.xml","form_type":"4"}},{"id":2551652,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":63544,"kind":"person","name":"DeFrancesco Lisa","position":1,"cik":"0001846325","reported_name":"DeFrancesco Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, IR & Corp. Affairs"}}],"security":"Common Stock","published_at":"2021-10-04T17:04:09.000Z","date":"2021-09-30","kind":"tax_withholding","acquired":false,"shares":204,"price":14.85,"value":3029.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person."}],"balance_after":10850,"source":{"system":"sec-edgar","filing":"0001104659-21-122561","document":"tm2129223-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465921122561/tm2129223-2_4seq1.xml","form_type":"4"}},{"id":2578876,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":63544,"kind":"person","name":"DeFrancesco Lisa","position":1,"cik":"0001846325","reported_name":"DeFrancesco Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, IR & Corp. Affairs"}}],"security":"Common Stock","published_at":"2021-09-03T19:00:50.000Z","date":"2021-09-01","kind":"tax_withholding","acquired":false,"shares":538,"price":15.05,"value":8096.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person."}],"balance_after":11054,"source":{"system":"sec-edgar","filing":"0001104659-21-113041","document":"tm2126933d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465921113041/tm2126933d1_4.xml","form_type":"4"}}]}